Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
5.98
-0.69 (-10.29%)
At close: May 9, 2025, 4:00 PM
6.02
+0.04 (0.75%)
After-hours: May 9, 2025, 7:59 PM EDT
Novavax Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Novavax stock have an average target of 17.5, with a low estimate of 7.00 and a high estimate of 26. The average target predicts an increase of 192.89% from the current stock price of 5.98.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Novavax stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Sell Maintains $9 → $7 | Sell | Maintains | $9 → $7 | +17.15% | May 9, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +217.99% | Dec 10, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +217.99% | Nov 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +217.99% | Nov 12, 2024 |
Jefferies | Jefferies | Strong Buy Maintains $31 → $25 | Strong Buy | Maintains | $31 → $25 | +318.41% | Oct 16, 2024 |
Financial Forecast
Revenue This Year
667.96M
from 682.16M
Decreased by -2.08%
Revenue Next Year
531.09M
from 667.96M
Decreased by -20.49%
EPS This Year
0.79
from -1.23
EPS Next Year
0.36
from 0.79
Decreased by -54.84%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 1.2B | 933.0M | 482.6M | ||
Avg | 668.0M | 531.1M | 324.4M | ||
Low | 318.5M | 314.2M | 161.6M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 75.0% | 39.7% | -9.1% | ||
Avg | -2.1% | -20.5% | -38.9% | ||
Low | -53.3% | -53.0% | -69.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 2.95 | 2.47 | 1.02 | ||
Avg | 0.79 | 0.36 | -0.07 | ||
Low | -1.27 | -1.13 | -0.74 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | 212.1% | 185.3% | ||
Avg | - | -54.8% | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.